Physician profile
Thomas Eddy
NPI 1528354693
$6,677.45
in general payments reported to CMS, 2019-2025
45 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $413 · 2021: $1,797 · 2022: $2,539 · 2023: $791 · 2024: $188 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,721.19 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Anika Therapeutics, INC. | $931.21 | 2021-2022 | |
| Horizon Therapeutics Plc | $685.33 | 2019-2023 | Krystexxa |
| Abbott Laboratories | $394.17 | 2021-2022 | |
| Zyla Life Sciences, INC. | $391.51 | 2019-2020 | |
| Boston Scientific Corporation | $276.90 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Paratek Pharmaceuticals, INC. | $228.82 | 2022-2023 | Nuzyra |
| Averitas Pharma INC. | $219.65 | 2023-2025 | Qutenza |
| Stryker Corporation | $194.28 | 2021-2024 | Variax, Citrefix |
| Smith+Nephew, INC. | $191.63 | 2020-2022 | |
| Grt US Holding, INC. | $171.30 | 2022 | |
| Heron Therapeutics, INC. | $109.61 | 2021 | |
| Bioventus LLC | $107.79 | 2021-2025 | Stimrouter Implantable Kit, Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $87.29 | 2022-2023 | Puraply |
| Vilex LLC | $84.28 | 2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Eddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.